Aware, Inc. (AWRE) on Q1 2021 Results - Earnings Call Transcript
Matt Glover: Good afternoon, and welcome to Aware’s First Quarter 2021 Earnings Conference Call. Joining us today is the company’s CEO and President, Robert Eckel; and CFO, David Barcelo. Following their remarks, we will open the call for questions. Before we begin today’s call, I’d like to remind everyone that the presentation today contains forward-looking statements that are based on the current expectations of Aware’s management and involve inherent risks and uncertainties that could cause actual results to differ materially from those described. Listeners should please take note of the safe harbor paragraph that is included at the end of today’s press release. This paragraph emphasizes the major uncertainties and risks inherent in forward-looking statements that management will be making today. Aware wishes to caution you that the factors that could cause actual results to differ materially from the results indicated by such statements. These risks and uncertainties are also outlined in the company’s SEC filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q.
Robert Eckel: Thanks, Matt. Good afternoon, everyone and thank you for joining us today. As you will soon here, we have some very exciting news. After the market closed, we issued a press release announcing our results for the first quarter ending March 31, 2021. A copy of the press release is available in the investor relations section of our website. So let me start by saying it’s a pleasure to join you all again for our second earnings call together. Just a few months ago, I had the chance to share a bit more about what Aware has managed to accomplish throughout 2020 in the company’s first earnings call a long time. Today, I plan to discuss the progress we’ve made throughout the first quarter and why we’re realistically optimistic about the remainder of the year and beyond. On this call, I’ll provide you with a high level overview with the quarters operation results, then I’ll turn it over to our CFO, Dave Barcelo, so that he can review the financial results for the quarter. I will then take some time to discuss what we have on our near and long-term horizons. After that, we will open the call for your questions. This quarter we generated our third consecutive period of top line growth. I’m excited about our increased subscription revenue, which shows our transformation is working. I’m also excited about entering the delivery phase on multiple federal government awards. These continue to bolster our reputation as a go-to U.S. company for their biometric needs. And of course, I’m excited about our record number of quarterly Knomi transactions. Dave and I will talk about significance of this shortly, but for now I’d like to highlight that there were more transactions protected by Knomi in the first quarter of 2021 than in any quarter previously.
David Barcelo: Thank you, Bob. Good afternoon to everyone on the call. Let’s turn to our financial results for the first quarter ended March 31, 2021. Our total revenue in the first quarter increased 26% to $4.4 million from $3.5 million in Q1 of last year. Sequentially, revenue increased 29% from $3.4 million in the prior quarter. Both the sequential and year-over-year increases were primarily due to increased subscription-based revenue related to growing transaction volume from existing customers and the upfront recognition of fixed minimum amounts from two new international wins. Turning our attention to operating expenses. For the first quarter of 2021 our operating expenses increased 21% to $5.9 million from $4.9 million in Q1 of last year. The quarterly increase was due primarily to an investment in additional sales and engineering resources in early 2020, and a full quarter of operating costs from our AFIX acquisition in late 2020. The corresponding operating loss for the first quarter of 2021 was $1.4 million compared to an operating loss of $1.3 million in the same year ago period.
Robert Eckel: Thanks very much, Dave. If you remember from the last call, I shared what we refer to as a three-part transformational growth strategy. I’d like to frame my discussion around those three core pillars and discuss the progress we’ve made so far and bringing this working strategy to fruition. Before getting to that though, earlier I indicated my excitement around some successes we had in the first quarter. Let me take a minute to tell you, how it’s an exciting time to be in a biometric space in general. From a market perspective, there was an increased attention to passwordless authentication in general, and consumers are becoming more confident in biometric technology. Particularly with the pandemic, consumers are looking for contactless and remote ways to verify their identity. We are seeing an increase in demand for touchless biometric solutions, as well as for remote onboarding and authentication, as entities continue to look for ways to conduct secure business transactions without requiring a face-to-face contact.
A - Matt Glover: Thank you, Bob. Our first question is, congratulations on the property sale. Can you discuss the company’s future real estate plan? Why now is the right time to sell the headquarters and what you plan to do with incremental capital?
Robert Eckel: So Matt, I’ll answer that. Earlier this year, when we received an unsolicited request from the developer and that was to purchase our office building is that for as part of a bid that they’re submitting for a big government project. And so in order to include potential purchase in the bid, we are required to negotiate terms and sign the purchase and sale agreement, which we just did. We just completed that. As such as material event, the signing must be disclosed in our SEC filings, which is why we included it in our 8-K, that said, a lot must happen. Timelines is uncertain, doesn’t necessarily mean that our building will be sold. But more importantly, the developer has to win the competitive bid from the government. And we don’t know that the outcome is of this for some time, but if we do proceed to a sale, details will be disclosed relative to regulations before the SEC.
Matt Glover: Thanks, Bob. Our next question is, when does the company intend to start disclosing subscription revenue?
David Barcelo: Thanks, Matt. I can take that. This is Dave Barcelo. And our subscription revenues are disclosed in the upcoming 10-Q. They are not on the space of financials since they have not hit a materiality threshold yet, but as they continue to grow, we are keeping an eye on that, but we have disclosed the – some of the subscription revenues for the quarter.
Matt Glover: Thanks, Dave. Our next question is how would you judge the current progress in commercial biometrics?
David Barcelo: Yes. So our progress has been very good so far, especially with the recent wins. I believe this quarter, the split between government and commercial is roughly 40-60, with 40% of our sales coming from commercial customers. So very happy with the progress there and with the success we’re having around the subscription revenues, which are largely coming from our commercial customers we expect that to – that trend to continue.
Matt Glover: Thanks, Dave. We have a probably another question for you. Can you provide more color on the two new international wins that are generating minimum revenues?
David Barcelo: Yes. So let me unpack that a little bit. So the two new international wins are coming from customers in various parts of the world. We continue to see great progress in Latin America both in Brazil, Mexico, and other parts of the region. So we’ve got a new customer in Latin America as well as added customer over in Europe. So seeing great geographic expansion here and it could progress. And then in terms of the minimum our subscription revenue is recognized a bit up front for these two customers, but we will see it recurring with annual renewals at the same levels.
Matt Glover: Thanks, Dave. We have another question. Can you provide a bit more context on the consumption-based revenues that you mentioned in the deck, very impressive transaction count this quarter, just trying to get a sense of how these transactions are converted into revenue and how you would be interpreting these transaction volumes?
David Barcelo: Yes. That’s a great question. It gives me a little opportunity to expand a little bit on the last bit. So our transaction count isn’t necessarily a direct correlation for the subscription revenue of the quarter. As I was hinting at before, we’ve got these monthly minimum. So our subscription-based customers fall into one of two categories, those with minimum annual commitments and those without. So if a customer has a minimum commitment, then the majority of that annual minimum is recognized upfront in that quarter. And then when they go over their minimum transaction counts, we’ll recognize the revenue as it occurs in that period throughout the year. But for customers that have no minimum, they fall into the latter part of that category and their revenue will be recognized at the time of usage in each quarter. So when you think about in aggregate volumes should be a good correlation for annual revenues, but we will be much more lumpy on a quarterly basis, due to these upfront minimums for some of the customer base.
Matt Glover: Thanks, Dave. Our next question. We’ve noticed that there’s been some pretty significant M&A activity in this space recently, particularly as it relates to Microsoft’s acquisition of Nuance, given how big they’ve now become. Do you think there is any room to compete on the speech recognition side? How much of an effect do you think the acquisition has on a word, the ability to compete in high growth verticals like healthcare?
Robert Eckel: Thanks, Matt. Well, first of all, it was never our intention to compete against Nuance in speech recognition. Their specialty is around speech recognition and the use cases associated with that. Like when you have a customer call the call center line and speak and answer to get routed to the appropriate representative. We are focused on, in our voice specialty is on speaker recognition, so the difference is, it’s less about what you say and more about verifying the identity of the person speaking. I did just mentioned, as speaker recognition becomes more important as an adjunct or as a fused option relative to face or finger or voice. I mean, or iris, this will also add or eliminate some of the multi-factor authentication needs and some of the friction. So all that being said, yes, we know how to do speech recognition, but it’s really about the identification of the individual based on their opting-in or their use, so it’s – we’re all about the speaker recognition. And so we don’t think the acquisition is going to impact our ability to go after speaker recognition use cases. It’s a matter of fact, we’re working on a couple right now and we’re targeting those in our high growth verticals, which include healthcare. And you’ve heard me talk about a healthcare opportunity that we just were able to close this quarter. And additionally, we have the proven expertise and experience for multimodal biometrics and use separately, as I said, or in combination in the enrollment process and the authentication process. And it’s a critical piece. That’s often overlooked by companies that specialize in speech recognition. So we’re confident that this acquisition won’t deter our success in our serviceable addressable market.
Matt Glover: Thanks, Bob. Our next question, I’ve noticed that a lot of close competitors and OEMs are providing healthcare, travel passes, digital IDs. It seems to be a trend that emerged post-COVID and is growing larger and larger. As Aware have a play in this space, or other there plans to work with a partner on implementing a solution like this?
Robert Eckel: Thanks. I mean, that obviously is a topic of the day and of the year. And as I stated before, we remain focused on our long-term strategy and we’re actively monitoring and discussing around vaccine passports in real close contact with resellers and customers regarding use of biometrics to secure those control. We believe that the health applications need to tie to a trusted identity to protect the user. The public and the information that the health app carries or being able to fraudulently documented or create another one is one that they’re facing right now. So we want to be able to, and we are providing biometrics to help enable that not to be the case that an individual can steal your vaccine identity now, or use that nefariously. So we do provide biometrics software to many system integrators, and we will enable them in turn to develop customer facing apps for many of these types of applications.
Matt Glover: Thanks, Bob. Can you shed some more light on when we’ll see the transformation pick up speed? What are some indicators that you’ve been through the bulk of the transformation? Should we expect to see – should we expect to be seeing subscription revenue overtake license revenue in a few quarters, few years?
Robert Eckel: Well, Dave may be able to add a little bit more color to it, but we can’t currently speak with greater certainty as we’re in the initial stages of our subscription transformation, both in our legacy perpetual license to subscription transformation, and then also our SaaS services. But as you can see, we do see a steady and positive increase and we’ve got some key indicators, we mentioned in the 10-Q as we go through this. And Dave talked about the high number of transactions and also the minimum, some of the subscriptions that we’ve set up. And also in the past calls, I’ve talked about term contracts where we’re looking to set up subscriptions, but at a longer-term, three and five years to get the quality of revenue and make sure that the customers are with us for a long time. And that also cuts down on their switching costs and it also gives us a good stand in that. So at this time, we’re seeing it pick up speed and we’re there to work with our customers from the smallest to the largest. And since we’ve been able to provide a subscription type service, we’ve been able to onboard more smaller players to enable them to make a bigger, I’ll say, a disruptive impact in the biometrics market.
Matt Glover: Thanks, Bob. We have another question. You talked a bit about lumpiness. Is there anything in the quarter to signify this quarter was a such as license payments or initial subscription payments that may not repeat next quarter?
Robert Eckel: Dave, do you want to take that one? I mean, I think we just talked about that a minute ago. But if you don’t want to, I can address it either way.
David Barcelo: Yes, Bob. And I think overall, the main message here is that our revenue should be looked at from the annual basis. There is some ups and downs. But yes, this will be our third consecutive quarter of growth. Q2, we’re looking to achieve what we can, but we do have some lumpiness in Q1 and for not projecting out what we’re doing on a quarterly basis.
Robert Eckel: Yes. Let me add to that a little bit. I think just to be clear, Dave added some discussed earlier on the lumpiness, some of our contracts, subscription contracts, let’s say they are three-year term or five-year term. Most of them have a minimum, so let’s say, okay, we’re going to do 1000 transactions or 100,000 transactions. So a lot of them have a minimum. Whenever that minimum is decided, the revenue will be recognized for that minimum entry level in that particular quarter. And then from there out, as they exceed those minimums, it’ll then be added to the subsequent quarters. So the following year, you’ll get the same hit again in that quarter. If you have a three-year contract, it will happen for three years or five and so forth. So there is some revenue recognition relative to the maintenance that’s pulled out and other things, but it’s very – if you’ve got a three-year term contract one a month for the whole year, you wouldn’t see any lumpiness, if it’s the same value. But again, just to be clear that we’re looking at things at a yearly basis. Hopefully that answered your question, Matt.
Matt Glover: Yes. Our next question is, if the subscription revenue is disclosed in the 10-Q, can you please tell us what the subscription revenue was in the quarter and last year?
Robert Eckel: Dave, you want to take that one?
David Barcelo: Yes. I can grab that, Bob. Yes, so this’ll be the first time we are disclosing subscription revenue. I think we’ve talked about it at our last earnings call, so happy to have it in the Q that will be released shortly. Our subscription revenue for the quarter was a shade under $800,000. And as you may have noted in the earnings release, we only mentioned that our quarterly subscription revenue was the same as or roughly the same as it was for all of last year, so certainly happy about that progress. And as we go forward, we will continue to disclose – we expect to continue to disclose the subscription revenue. And once it becomes material it should be included in the face of the contract – sorry, face of the 10-Q.
Matt Glover: Thanks, Dave. So we have a follow-up question. Thank you for adding color on the company’s plans for inorganic growth via strategic M&A. We’d love to understand how the company thinks about share repurchase versus acquisitions, especially in light of the 2020 share repurchase authorization.
Robert Eckel: Yes. Let me take that. Well, one thing, I mean, you can just see what we have, I think I mentioned in the call and I know I mentioned in the call that we’re looking at opportunities, we picked up what we believe was a good match for us. And so we’re doing trade-offs as we go relative to what’s the best way to use our cash. So overall, we have the opportunity and we have the flexibility to do that, and we make that on a quarterly basis. And as I said, we’re actively looking to focus on our long-term growth strategy and in that there’s those decisions that we make and have a discussion around pending if we find good fits externally. And also whether there’s some opportunities internally where we want to accelerate for instance, our SaaS services or offerings. So I know it’s a long-winded question, but there are a bunch of trades that go into that, and it’s not a simple, are we going to resume or not resume? We have the option the way we are set up to be able to do what’s best for the company.
Matt Glover: Thanks Bob. At this time, this concludes our question-and-answer session. If your question wasn’t answered, please e-mail Aware’s IR team at aware@gatewayir.com. Now I’d like to turn the call back over to Bob for closing remarks.
Robert Eckel: Well, I want to thank all of you for joining us on today’s call. During our last call, we mentioned that we’d be releasing an investor presentation, detaining a bit more of information about the strategy that we outlined last time in here. And that presentation is now available on Aware’s investor relations website. And, I’d be remiss if I didn’t especially thank our employees, partners, investors for their and your continued support. And we look forward to updating you on our next call. So with that, Matt…
Matt Glover: We’d like to remind everyone that a recording of today’s call will be available for replay via link available in the Investors section of the company’s website. Thank you for joining today for Aware’s first quarter 2021 earnings conference call. You may now disconnect.
